Explore HSN-003839, a novel USP21 inhibitor showing promise in cancer therapy by targeting the ubiquitin-proteasome system.
Discover how transcriptional profiling is revolutionizing our understanding of skeletal muscle atrophy and leading to new therapeutic approaches.
Discover how the long non-coding RNA A1BG-AS1 promotes osteosarcoma progression through molecular mechanisms and potential therapeutic targets.
Explore the scientific journey to improve Delta F508 CFTR surface expression in cystic fibrosis treatment through innovative research and therapies.
Exploring how endocytosis regulates developmental signaling pathways, from cellular processes to embryonic development.
Explore how the ubiquitin system functions as the cell's protein disposal mechanism and its emerging role as a therapeutic target in lung cancer treatment.
Discover how RAD6 inhibition sensitizes triple-negative breast cancer to platinum-based therapy, offering new hope for TNBC patients.
Explore how spatial transcriptomics is revolutionizing our understanding of focal cortical dysplasia type IIb and drug-resistant epilepsy through molecular mapping of brain tissues.
Exploring how Alzheimer's disease progressively impacts language and communication, with research-backed strategies for maintaining connection.
Discover how rolling-translated EGFR variants sustain signaling in glioblastoma through circular RNA mechanisms and their clinical implications.